Gluten exorphin B5 stimulates prolactin secretion through opioid receptors located outside the blood-brain barrier

Life Sciences

Volumn 76, Issue 15, 2005, Pages 1713-1719

  Fanciulli, Giuseppe ^a   Dettori, Alessandra ^a   Demontis, Maria P ^a   Tomasi, Paolo A ^a   Anania, Vittorio ^a   Delitala, Giuseppe ^a  

^a UNIVERSITY OF SASSARI   (Italy)

Author keywords

Blood Brain Barrier; Food opioids; Gluten exorphins; Opioid peptides; Pituitary; Prolactin

Indexed keywords

17 METHYLNALOXONE BROMIDE; GLUTEN EXORPHIN B5; OPIATE PEPTIDE; OPIATE RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BLOOD BRAIN BARRIER; BLOOD SAMPLING; BODY WEIGHT; CONTROLLED STUDY; DOPAMINERGIC ACTIVITY; DRUG ACTIVITY; MALE; NEUROTRANSMISSION; NONHUMAN; PROLACTIN RELEASE; RAT; STATISTICAL SIGNIFICANCE;

TRITICUM AESTIVUM;

EID: 13444288042     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2004.09.023     Document Type: Article

References (27)

1. P. Buydens, B. Velkeniers, J. Golstein, E. Finne, and L. Vanhaelst Opioid modulation of thyrotropin releasing hormone induced prolactin secretion Life Sciences 40 12 1987 1207 1214
2. G. Delitala Opiate receptors in the neuroregulation of prolactin, growth hormone and thyroid-stimulating hormone secretion M. Negri G. Lotti A. Grossman Endogenous Opioid Peptides 1992 John Wiley and Sons Chichester 73 87
3. G. Fanciulli, A. Dettori, P.A. Tomasi, M.P. Demontis, S. Gianorso, V. Anania, and G. Delitala Prolactin and growth hormone response to intracerebroventricular administration of the food opioid peptide gluten exorphin B5 in rats Life Sciences 71 20 2002 2383 2390
4. G. Fanciulli, A. Dettori, E. Fenude, M.P. Demontis, E. Alberico, G. Delitala, and V. Anania Intravenous administration of the food-derived opioid peptide gluten exorphin B5 stimulates prolactin secretion in rats Pharmacological Research 47 1 2003 53 58
5. S. Fukudome, and M. Yoshikawa Opioid peptides derived from wheat gluten: their isolation and characterization FEBS Letters 296 1 1992 107 111
6. S. Fukudome, and M. Yoshikawa Gluten exorphin C. A novel opioid peptide derived from wheat gluten FEBS Letters 316 1 1993 17 19
7. S. Fukudome, A. Shimatsu, H. Suganuma, and M. Yoshikawa Effect of gluten exorphins A5 and B5 on the postprandial plasma insulin level in conscious rats Life Sciences 57 7 1995 729 734
8. S. Fukudome, Y. Jinsmaa, T. Matsukawa, R. Sasaki, and M. Yoshikawa Release of opioid peptides, gluten exorphins by the action of pancreatic elastase FEBS Letters 412 3 1997 475 479
9. W.F. Ganong Circumventricular organs: definition and role in the regulation of endocrine and autonomic function Clinical and Experimental Pharmacology and Physiology 27 5-6 2000 422 427
10. P.M. Gross Circumventricular organ capillaries Progress in Brain Research 9 1992 219 233
11. R.C. Hemmer, G.A. Olson, A.J. Kastin, J.H. McLean, and R.D. Olson Effects of naloxone and its quaternary form on fluid consumption in rats Pharmacology, Biochemistry and Behavior 17 6 1982 1287 1290
12. S. Husby, J.C. Jensenius, and S.E. Svehag Passage of undegraded dietary antigen into the blood of healthy adults. Quantification, estimation of size distribution, and relation of uptake to levels of specific antibodies Scandinavian Journal of Immunology 22 1 1985 83 92
13. S. Husby, J.C. Jensenius, and S.E. Svehag Passage of undegraded dietary antigen into the blood of healthy adults. Further characterization of the kinetics of uptake and the size distribution of the antigen Scandinavian Journal of Immunology 24 4 1986 447 455
14. D. Jezova Stimulation of ACTH release by naloxone: central or peripheral action? Life Sciences 37 11 1985 1007 1013
15. D.W. Johnson, M.A. Barnes, R.M. Akers, and R.E. Pearson A synthetic opioid peptide increases plasma growth hormone and prolactin in Holstein calves Journal of Animal Science 71 4 1993 1004 1009
16. A.M. Knivsberg, K.L. Reichelt, T. Hoien, and M. Nodland A randomised, controlled study of dietary intervention in autistic syndromes Nutritional Neuroscience 5 4 2002 251 261
17. 1-receptors of the development of genetic hypertension but not its heritability British Journal of Pharmacology 115 4 1995 557 562
18. A. Mansour, H. Khachaturian, M.E. Lewis, H. Akil, and S.J. Watson Autoradiographic differentiation of mu, delta, and kappa opioid receptors in the rat forebrain and midbrain The Journal of Neuroscience 7 8 1987 2445 2464
19. A. Mansour, C.A. Fox, S. Burke, F. Meng, R.C. Thompson, H. Akil, and S.J. Watson Mu, delta, and kappa opioid receptor mRNA expression in the rat CNS: an in situ hybridization study The Journal of Comparative Neurology 350 3 1994 412 438
20. K.E. Moore Interactions between prolactin and dopaminergic neurons Biology of Reproduction 36 1 1987 47 58
21. A.E. Panerai, F. Casanueva, A. Martini, P. Mantegazza, and A.M. Di Giulio Opiates act centrally on GH and PRL release Endocrinology 108 6 1981 2400 2402
22. K.L. Reichelt, and A.M. Knivsberg Can the pathophysiology of autism be explained by the nature of the discovered urine peptides? Nutritional Neuroscience 6 1 2003 19 28
23. J.F. Remme, S. Koetzner, K. Haugland, K.L. Reichelt, and G.O. Bronstadt Analysis of neuroactive peptides with LC/MS in the urine of autistic patients Proceedings of the 49th ASMS conference on Mass Spectrometry and Allied Topics, Chicago, Illinois, May 27-31 2001
24. J.W. Simpkins, D. Swager, and W.J. Millard Evaluation of the sites of opioid influence on anterior pituitary hormone secretion using a quaternary opiate antagonist Neuroendocrinology 54 4 1991 384 390
25. H. Teschemacher Opioid receptor ligands derived from food proteins Current Pharmaceutical Design 9 16 2003 1331 1344
26. F.M. van Overbeek, I.G. Uil-Dieterman, I.W. Mol, L. Kohler-Brands, H.S. Heymans, and C.J. Mulder The daily gluten intake in relatives of patients with coeliac disease compared with that of the general Dutch population European Journal of Gastroenterology and Hepatology 9 11 1997 1097 1099
27. P. Whiteley, and P. Shattock Biochemical aspects in autism spectrum disorders: updating the opioid-excess theory and presenting new opportunities for biomedical intervention Expert Opinion on Therapeutic Targets 6 2 2002 175 183